Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
US10059716B2 · kind B2 · utility
42Cited by
4References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H7/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.